Stora Enso’s historical figures according to IFRS 11

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Stora Enso’s historical figures according to IFRS 11 Joint Arrangements

Helsinki, Finland, 2014-03-19 08:00 CET (GLOBE NEWSWIRE) -- STORA ENSO OYJ STOCK EXCHANGE RELEASE 19 March 2014 at 9.00 EET Stora Enso adopted the new IFRS 11 Joint Arrangements as of 1 January 2014. The change affects the accounting treatment of Montes del Plata and Veracel which are now treated as joint operations and thus Stora Enso’s 50% ownership is consolidated with the line-by-line method. Previously these two entities were consolidated using the equity method. The line by line consolidation of Stora Enso’s 50% ownership of Montes del Plata and Veracel has no impact on published operational EBIT, net profit, equity or earnings per share. The line by line consolidation impacts all the primary statements in the consolidated financial statements. The impacts are summarised below:

  • Increase in operational EBITDA
  • Increase in property, plant and equipment, biological assets and net debt
  • Decrease in equity accounted investment
  • Increase in capital expenditure and decreases in equity injections to equity accounted investments.

Historical figures according to the new standard are presented in the tables below. Additionally, the Group has revised the presentation of the cash flow statement to reflect better the underlying cash movements. CTA = Cumulative Translation Adjustment, EAI = Equity Accounted Investments, NCI = Non-controlling Interests, NRI = Non-recurring Items, OCI = Other Comprehensive Income Effects of Changes to IFRS 11 Joint Arrangements

  Restated   Change   As published
EUR million 2013 2012   2013 2012   2013 2012
Sales 10 563 10 837   19 22   10 544 10 815
Operational EBITDA 1 090 1 154   46 60   1 044 1 094
Operational EBIT 578 630   - -   578 630
Operating profit (IFRS) 50 716   16 15   34 701
Net profit/loss for the period -71 490   - -   -71 490
                 
Capital expenditure 760 1 012   335 456   425 556
Depreciation and impairment charges excl. NRI 603 623   39 40   564 583
                 
Operational ROCE, % 6.5 6.9   -0.6 -0.4   7.1 7.3
Return on equity (ROE), % -1.3 8.3   - -   -1.3 8.3
Debt/equity ratio 0.61 0.58   0.14 0.10   0.47 0.48
Net debt/last twelve months’ operational EBITDA 2.9 2.9   0.6 0.4   2.3 2.5
Equity ratio, % 39.2 41.0   -2.1 -1.8   41.3 42.8
                 
Capital structure                
Operative fixed assets 6 824 7 520   1 590 1 498   5 234 6 022
Equity accounted investments 1 013 941   -948 -1 024   1 961 1 965
Operative working capital, net 1 179 1 526   94 66   1 085 1 460
Non-current interest-free items, net -466 -551   33 60   -499 -611
Operating Capital Total 8 550 9 436   769 600   7 781 8 836
Net tax liabilities -86 -237   -12 -20   -74 -217
Capital Employed 8 464 9 199   757 580   7 707 8 619
                 
Equity attributable to owners of the Parent 5 213 5 770   - -   5 213 5 770
Non-controlling interests 60 92   - -   60 92
Net interest-bearing liabilities 3 191 3 337   757 580   2 434 2 757
Financing Total 8 464 9 199   757 580   7 707 8 619

Key Figures – Restated

EUR million 2013 Q4/13 Q3/13 Q2/13 Q1/13 2012
Sales 10 563 2 612 2 553 2 726 2 672 10 837
Operational EBITDA 1 090 260 319 257 254 1 154
Operational EBITDA margin, % 10.3 10.0 12.5 9.4 9.5 10.6
Operational EBIT 578 152 184 124 118 630
Operational EBIT margin, % 5.5 5.8 7.2 4.5 4.4 5.8
Operating profit (IFRS) 50 -210 156 83 21 716
Operating margin (IFRS), % 0.5 -8.0 6.1 3.0 0.8 6.6
Profit before tax excl. NRI 350 111 126 57 56 314
Loss/profit before tax -189 -281 103 24 -35 478
Net profit for the period excl. NRI 323 118 104 45 56 263
Net loss/profit for the period -71 -160 84 21 -16 490
             
Capital expenditure 760 278 168 184 130 1 012
Depreciation and impairment charges excl. NRI 603 136 157 154 156 623
             
Operational ROCE, % 6.5 7.0 8.3 5.4 5.1 6.9
             
Earnings per share (EPS) excl. NRI, EUR 0.40 0.15 0.13 0.05 0.07 0.33
EPS (basic), EUR -0.07 -0.18 0.11 0.02 -0.02 0.61
Cash earnings per share (CEPS) excl. NRI, EUR 1.16 0.31 0.33 0.25 0.27 1.13
CEPS, EUR 1.21 0.46 0.31 0.21 0.23 1.35
             
Return on equity (ROE), % -1.3 -11.9 6.2 1.5 -1.1 8.3
Debt/equity ratio 0.61 0.61 0.64 0.68 0.61 0.58
Net debt/last twelve months’ operational EBITDA 2.9 2.9 3.1 3.2 3.1 2.9
Equity per share, EUR 6.61 6.61 6.82 6.67 7.32 7.32
Equity ratio, % 39.2 39.2 39.2 38.7 40.7 41.0
             
Average number of employees 28 921 28 453 28 997 29 357 28 887 29 385

Reconciliation of Operational Profitability – Restated

EUR million 2013 Q4/13 Q3/13 Q2/13 Q1/13 2012
Operational EBITDA 1 090 260 319 257 254 1 154
Equity accounted investments (EAI), operational 91 28 22 21 20 99
Depreciation and impairment excl. NRI -603 -136 -157 -154 -156 -623
Operational EBIT 578 152 184 124 118 630
Fair valuations and non-operational items 11 30 -5 -8 -6 -44
Non-recurring items -539 -392 -23 -33 -91 130
Operating Profit/Loss (IFRS) 50 -210 156 83 21 716

Capital Structure – Restated

EUR million 31 Dec 13 30 Sep 13 30 Jun 13 31 Mar 13 31 Dec 12
Operative fixed assets 6 824 7 159 7 130 7 511 7 520
Equity accounted investments 1 013 1 003 982 980 941
Operative working capital, net 1 179 1 470 1 518 1 640 1 526
Non-current interest-free items, net -466 -534 -535 -544 -551
Operating Capital Total 8 550 9 098 9 095 9 587 9 436
Net tax liabilities -86 -196 -189 -216 -237
Capital Employed 8 464 8 902 8 906 9 371 9 199
           
Equity attributable to owners of the Parent 5 213 5 381 5 261 5 772 5 770
Non-controlling interests 60 86 88 89 92
Net interest-bearing liabilities 3 191 3 435 3 557 3 510 3 337
Financing Total 8 464 8 902 8 906 9 371 9 199

Cash Flow – Restated

EUR million 2013 Q4/13 Q3/13 Q2/13 Q1/13 2012
Operational EBITDA 1 090 260 319 257 254 1 154
NRI on Operational EBITDA 37 154 -23 -43 -51 18
Dividends received from EAI 38 18 2 7 11 102
Other adjustments -178 -168 1 8 -19 -25
Change in working capital 265 198 48 88 -69 45
Cash Flow from Operations 1 252 462 347 317 126 1 294
Cash spent on fixed and biological assets -740 -216 -182 -170 -172 -1 000
Acquisitions of equity accounted investments -31 - -1 -30 - -
Cash Flow after Investing Activities 481 246 164 117 -46 294

Condensed Consolidated Income Statement – Restated

EUR million 2013 Q4/13 Q3/13 Q2/13 Q1/13 2012
             
Sales 10 563 2 612 2 553 2 726 2 672 10 837
 Other operating income 140 34 30 37 39 219
 Materials and services -6 550 -1 488 -1 585 -1 765 -1 712 -6 890
 Freight and sales commissions -982 -235 -237 -251 -259 -1 011
 Personnel expenses -1 390 -349 -314 -368 -359 -1 373
 Other operating expenses -644 -141 -149 -165 -189 -611
 Share of results of equity accounted investments 102 49 15 13 25 117
 Depreciation and impairment -1 189 -692 -157 -144 -196 -572
Operating Profit/Loss 50 -210 156 83 21 716
 Net financial items -239 -71 -53 -59 -56 -238
Loss/Profit before Tax -189 -281 103 24 -35 478
 Income tax 118 121 -19 -3 19 12
Net Loss/Profit for the Period -71 -160 84 21 -16 490

Condensed Consolidated Statement of Cash Flows – Restated

EUR million 2013 Q1–Q3/13 Q1–Q2/13 Q1/13 2012
Cash Flow from Operating Activities          
Operating profit 50 260 104 21 716
Hedging result from OCI 7 - 10 -1 -2
Adjustments for non-cash items 937 463 320 174 533
Change in net working capital 265 67 19 -69 45
Cash Flow Generated by Operations 1 259 790 453 125 1 292
Net financial items paid -198 -134 -86 -66 -161
Income taxes paid, net -46 -33 -20 -3 -105
Net Cash Provided by Operating Activities 1 015 623 347 56 1 026
           
Cash Flow from Investing Activities          
Acquisitions of subsidiaries and business operations, net of acquired cash 25 - - - -11
Acquisitions of equity accounted investments -31 -31 -30 - -
Acquisitions of available-for-sale investments -9 -9 -9 - -
Proceeds from sale of fixed assets and shares, net of disposed cash 96 87 81 18 11
Proceeds from disposal of available-for-sale investments 42 43 - - -
Capital expenditure -740 -524 -342 -172 -1 000
Proceeds from/payments of non-current receivables, net 85 107 98 2 -4
Net Cash Used in Investing Activities -532 -327 -202 -152 -1 004
           
Cash Flow from Financing Activities          
Proceeds from issue of new long-term debt 239 223 66 - 1 766
Long-term debt, payments -415 -189 -44 -39 -604
Change in short-term borrowings 108 131 47 -15 -155
Dividends paid -237 -237 -237 - -237
Dividend to non-controlling interests -7 -6 -6 -7 -3
Net Cash Used in/Provided by Financing Activities -312 -78 -174 -61 767
           
Net Increase/Decrease in Cash and Cash Equivalents 171 218 -29 -157 789
Translation adjustment -27 -16 -20 3 -28
Net cash and cash equivalents at the beginning of period 1 917 1 917 1 917 1 917 1 156
Net Cash and Cash Equivalents at Period End 2 061 2 119 1 868 1 763 1 917
           
Cash and Cash Equivalents at Period End 2 073 2 121 1 869 1 764 1 921
Bank Overdrafts at Period End -12 -2 -1 -1 -4
Net Cash and Cash Equivalents at Period End 2 061 2 119 1 868 1 763 1 917

Condensed Consolidated Statement of Financial Position – Restated

EUR million   31 Dec 13 30 Sep 13 30 Jun 13 31 Mar 13 31 Dec 12
             
Assets            
             
Non-current Assets            
  PPE*, goodwill and other intangible assets O 5 808 6 332 6 370 6 573 6 565
  Biological assets O 634 454 466 496 474
  Emission rights O 21 18 15 35 30
  Equity accounted investments O 1 013 1 003 982 980 941
  Available-for-sale: Interest-bearing I 10 10 105 100 96
  Available-for-sale: Operative O 361 355 279 407 451
  Non-current loan receivables I 80 79 37 137 134
  Deferred tax assets T 229 165 162 169 143
  Other non-current assets O 63 70 69 80 85
    8 219 8 486 8 485 8 977 8 919
             
Current Assets            
  Inventories O 1 445 1 515 1 510 1 610 1 510
  Tax receivables T 13 14 15 18 18
  Operative receivables O 1 555 1 676 1 787 1 851 1 714
  Interest-bearing receivables I 147 137 151 196 211
  Cash and cash equivalents I 2 073 2 121 1 869 1 764 1 921
    5 233 5 463 5 332 5 439 5 374
             
Total Assets   13 452 13 949 13 817 14 416 14 293
             
Equity and Liabilities            
             
  Owners of the Parent   5 213 5 381 5 261 5 772 5 770
  Non-controlling Interests   60 86 88 89 92
Total Equity   5 273 5 467 5 349 5 861 5 862
             
Non-current Liabilities            
 Post-employment benefit provisions O 378 465 461 470 480
 Other provisions O 127 124 133 145 145
 Deferred tax liabilities T 312 331 337 361 358
 Non-current debt I 4 163 4 333 4 260 4 817 4 799
 Other non-current operative liabilities O 24 15 10 9 11
    5 004 5 268 5 201 5 802 5 793
Current Liabilities            
 Current portion of non-current debt I 544 644 732 221 202
 Interest-bearing liabilities I 794 805 727 669 698
 Operative liabilities O 1 821 1 721 1 779 1 821 1 698
 Tax liabilities T 16 44 29 42 40
    3 175 3 214 3 267 2 753 2 638
             
Total Liabilities   8 179 8 482 8 468 8 555 8 431
             
Total Equity and Liabilities   13 452 13 949 13 817 14 416 14 293

* PPE = Property, Plant and Equipment Items designated with “O” comprise Operating Capital Items designated with “I” comprise Interest-bearing Net Liabilities Items designated with “T” comprise Net Tax Liabilities  

For further information, please contact: Seppo Parvi, CFO, tel. +358 2046 21205 Ulla Paajanen-Sainio, SVP, I nvestor Relations, tel. +358 2046 21242 www.storaenso.com www.storaenso.com/investors Stora Enso is the global rethinker of the paper, biomaterials, wood products and packaging industry. We always rethink the old and expand to the new to offer our customers innovative solutions based on renewable materials. Stora Enso employs some 28 000 people worldwide, and our sales in 2013 amounted to EUR 10.5 billion. Stora Enso shares are listed on NASDAQ OMX Helsinki (STEAV, STERV) and Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY) in the International OTCQX over-the-counter market. STORA ENSO OYJ

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TagniFi Spread: AI Transforming Financial Analysis

Updated Category News Views 40

Ah, finance folks, we've all been there—lost in the trenches, teeth gritted as we manually grind through private company financials. It's like trying to piece together a 1,000-piece jigsaw puzzle without a picture of the final scene. But now, someone's come along and flipped on the light switch. Enter TagniFi Spread, the new AI-powered tool that's snapped a whole lot of...

Continue Reading
Atomic Mobile's Global IoT Game Changer in Connectivity

Updated Category News Views 83

Atomic Orbit Unlocks Global Connectivity Think about the hassle businesses face globally when devices drop off the grid. It's like losing a lifeline. Atomic Mobile, outta Spring Lake, decided enough's enough and dropped their latest brainchild on the world — Atomic Orbit. This bad boy is turning heads because it's not clinging to a single carrier. Instead, it's dancing...

Continue Reading
Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Updated Category News Views 93

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Continue Reading
Hydden Welcomes Cybersecurity Veteran Charles Tango as CSO

Updated Category News Views 83

Unpacking Charles Tango's Move to Hydden Nobody expects cybersecurity to be a stroll in the park, and it looks like Hydden just upped its game by bringing in Charles Tango, a heavyweight turned strategy guru. You might not know him, but this guy's got a track record that shouldn’t be ignored—like a grizzled old prizefighter just itching for a new opponent. A Veteran...

Continue Reading
Emotional Products Steal the Show at Canton Fair

Updated Category News Views 91

Canton Fair's Emotional Revolution Amidst the bustling aisles of the 140th Canton Fair in Guangzhou, something interesting has gotten folks buzzing. The market's tilting its head towards products that spark joy and dance with emotion, rather than just bland utility. That's right, the time-honored relationship between value and function is giving way to a softer kind of...

Continue Reading
Jennifer Wills Takes Helm as Sole CEO of Kelleher

Updated Category News Views 175

Jennifer Wills Leads Kelleher International Forward There's a fresh breeze blowing through the halls of Kelleher International, the luxury matchmaking firm. Jennifer Wills, a savvy player with her roots in law and finance, has stepped up as the sole CEO. After a decade of busting her chops at the firm, it's high time she's taken the helm. This ain't just a job transition;...

Continue Reading
Pavlus Travel's Bucket-List Trips in High Demand for 2027

Updated Category News Views 16

Luxury Travel is Having a Moment A fancy vacation isn't just a postcard on the wall anymore—it's now, more than ever, a box folks are itching to check off their lists. Call it a midlife shift or just the world shrugging off its pandemic blues, but high-end travelers are saying, "The time is now," and they're serious. Pavlus Travel, a top name in the lux travel space,...

Continue Reading
Stellus Capital Set to Unveil Q3 Results: Key Details

Updated Category News Views 138

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 58

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Webull Corp Caught in Legal Storm; Investors Take Note

Updated Category News Views 87

A Legal Storm Brewing It's like walking into a saloon, expecting a smooth drink, only to find a bar fight breaking out in front of you. That's the scene with Webull Corporation (NASDAQ: BULL) right now. This time, they ain't just shooting the breeze; they're in the line of legal fire. SBS Law, a heavyweight in shareholder rights, is rallying the troops for a class action...

Continue Reading

Top 5 Most Recently Viewed Articles

Astounding Returns: Gilead Sciences Investment Over Two Decades

Updated Category News Views 209

Gilead Sciences: A Long-Term Investment Perspective Gilead Sciences Inc. (NASDAQ: GILD) has demonstrated impressive performance in the stock market, significantly outperforming general market indices over the past two decades. The company has achieved an average annual return of 12.17%, surpassing the broader market by 3.67% annually, indicating a strong investment...

Continue Reading
ValueMomentum Shines as Rising Star in Global Insurance Services

Updated Category News Views 127

ValueMomentum Honored as a Rising Star in Insurance Services ValueMomentum is making headlines as a leading provider of solutions and services, especially for property and casualty (P&C) insurers. Recently, the company was recognized as a Rising Star in the 2025 ISG Provider Lens report focused on Global Insurance Services. This acknowledgment highlights the company's...

Continue Reading
Urgent Call for Safer Baby Sleep Standards Promoted by Experts

Updated Category News Views 89

Reassessing Infant Sleep Safety: A Call for Change Breathe Easy Baby™, a leader in breathable crib mattress technology, urges updates to infant sleep-safety standards as sleep-related deaths remain a national concern. In recent years, sleep-related deaths in infants have persisted as a tragic reality. The CDC reported that approximately 3,700 Sudden Unexpected Infant...

Continue Reading
Agree Realty Corporation Announces Dividend for Shareholders

Updated Category News Views 179

Agree Realty Corporation's Monthly Dividend Declaration Today, Agree Realty Corporation (NYSE: ADC) has made an important announcement regarding its financial commitments to shareholders. The Board of Directors has approved a monthly cash dividend of $0.256 per common share. This new dividend signals a robust annualized dividend amount of $3.072 per common share, marking...

Continue Reading
Resilient Stocks to Watch Amid Market Volatility and Buybacks

Updated Category News Views 135

Technology Stock Turbulence and Emerging Leaders Recently, the technology sector has experienced notable fluctuations, with market dynamics showcasing volatility. The tech-heavy index reached impressive highs before witnessing a significant drop. This fluctuation has created both challenges and opportunities within different sectors. While some stocks are on a...

Continue Reading